Sutro Biopharma Inc.

1.45
-0.14 (-8.81%)
At close: Mar 03, 2025, 3:59 PM
1.45
0.66%
After-hours: Mar 03, 2025, 04:56 PM EST

Sutro Biopharma Ratios Statement

Year FY23 FY22 FY21 FY20 FY19 FY18 FY17 FY16
PE Ratio -2.42 -3.44 -6.31 -19.53 -4.53 -1.47 -5.4 62.49
PEG Ratio 0.10 8.12 -0.06 0.36 0.08 -0.01 0.00 n/a
PS Ratio 1.68 6.05 11.09 16.55 5.91 1.35 2.06 1.78
PB Ratio 1.72 1.89 2.72 2.13 2.58 0.39 -0.98 -1.17
P/FCF Ratio -2.23 -95.14 -7.07 -9.44 -3.69 4.67 -2.63 -6.06
P/OCF Ratio -2.31 115.52 -8.4 -10.43 -3.88 4.10 -2.87 -8.09
OCF/S Ratio -0.73 0.05 -1.32 -1.59 -1.52 0.33 -0.72 -0.22
Debt / Equity Ratio 0.22 0.31 0.23 0.07 0.10 0.11 -0.13 -0.01
Quick Ratio 4.50 2.30 5.24 12.78 3.90 5.76 0.80 0.99
Current Ratio 4.50 2.22 5.24 12.78 3.90 5.76 0.80 0.99
Asset Turnover 0.33 0.17 0.18 0.11 0.27 0.17 1.27 0.86
Interest Coverage -3.76 -38.54 -31.41 -17.43 -12.75 -22.93 -31.49 n/a
Return on Equity (ROE) -0.71 -0.55 -0.43 -0.11 -0.57 -0.27 0.18 -0.02
Return on Assets (ROA) -0.23 -0.29 -0.32 -0.09 -0.36 -0.16 -0.48 0.02
Return on Capital (ROIC) -0.24 -0.48 -0.33 -0.19 -0.45 -0.2 -2.19 0.07
Dividend Yield n/a n/a n/a n/a n/a n/a n/a n/a
Payout Ratio n/a n/a n/a n/a n/a n/a n/a n/a
Gross Profit Margin 95.57% 87.77% 84.21% -80.14% -53.53% -41.24% -0.3% 27.09%
Net Profit Margin -69.47% -175.89% -175.62% -84.75% -130.44% -91.93% -38.05% 2.85%
Pretax Profit Margin -57.63% -172.2% -170.55% -75.2% -130.44% -91.93% -38.05% 2.85%
Operating Profit Margin -58.07% -190.26% -159.22% -166.32% -129.79% -96.89% -37.25% 2.28%
FCF Margin -75.41% -6.36% -156.76% -175.39% -160.3% 28.96% -78.06% -29.38%
EBITDA Margin -44.18% -155.03% -159.22% -55.6% -109.08% -85.42% -27.22% 12.33%